Loss of IFN-γ pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy

Gao, Jianjun, Shi, Lewis Zhichang, Zhao, Hao, Chen, Jianfeng, Xiong, Liangwen, He, Qiuming, Chen, Tenghui, Roszik, Jason +8 more·2016·Cell

DOI 10.1016/j.cell.2016.08.069

Cited by (1,000)

Items 601–700 of 1,000

Polycomb Directed Cell Fate Decisions in Development and Cancer
Beatriz German, Leigh Ellis · 2022 · Epigenomes
Interaction of molecular alterations with immune response in melanoma
Robert A. Szczepaniak Sloane, Vancheswaran Gopalakrishnan, Sangeetha Meda Reddy, Xue Zhang, Alexandre Reuben, Jennifer Ann Wargo · 2017 · Cancer
Constitutive and acquired mechanisms of resistance to immune checkpoint blockade in human cancer
Matteo Bellone, Angela Rita Elia · 2017 · Cytokine & Growth Factor Reviews
Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinoma
Nicholas Haig Chakiryan, Youngchul Kim, Anders Berglund, Andrew C. Chang, Gregory J. Kimmel, Ali J. Hajiran, Jonathan V. Nguyen, Carlos Moran Segura, Daryoush Saeed‐Vafa, Esther N. Katende et al. · 2023 · Journal for ImmunoTherapy of Cancer
Immune Checkpoint-Mediated Interactions Between Cancer and Immune Cells in Prostate Adenocarcinoma and Melanoma
Angela Rita Elia, Sara Caputo, Matteo Bellone · 2018 · Frontiers in Immunology
A Review of Key Biological and Molecular Events Underpinning Transformation of Melanocytes to Primary and Metastatic Melanoma
Louise A. Jackett, Richard A. Scolyer · 2019 · Cancers
Immunotherapy in anaplastic thyroid cancer.
Maoguang Ma, Bo Lin, Ming‐Dian Wang, Xiaoli Liang, Lei Su, Okenwa C. Okose, Weiming Lv, Jie Li · 2020 · PubMed Central
The Complex Role of EZH2 in the Tumor Microenvironment: Opportunities and Challenges for Immunotherapy Combinations
Jing Qiu, Shikhar Sharma, Robert A. Rollins, Thomas A. Paul · 2020 · Future Medicinal Chemistry
Prevention of dsRNA‐induced interferon signaling by AGO1x is linked to breast cancer cell proliferation
Souvik Ghosh, Joao C. Guimaraes, Manuela Lanzafame, Alexander Schmidt, Afzal P Syed, Beatrice Dimitriades, Anastasiya Börsch, Shreemoyee Ghosh, Nitish Mittal, Thomas C. Montavon et al. · 2020 · The EMBO Journal
Using CRISPR to enhance T cell effector function for therapeutic applications
Julian J. Freen‐van Heeren · 2020 · Cytokine X
Blinatumomab-induced T cell activation at single cell transcriptome resolution
Yi Huo, Zhen Sheng, Daniel Lu, Daniel Christian Ellwanger, Chi-Ming Li, Oliver R. Homann, Songli Wang, Hong Mei Yin, Ruibao Ren · 2021 · BMC Genomics
Next generation immunotherapy: enhancing stemness of polyclonal T cells to improve anti-tumor activity
Rigel J. Kishton, Suman Kumar Vodnala, Raul Vizcardo, Nicholas P. Restifo · 2021 · Current Opinion in Immunology
Bridging Radiotherapy to Immunotherapy: The IFN–JAK–STAT Axis
Lewis Z. Shi, James A. Bonner · 2021 · International Journal of Molecular Sciences
miRNA as a Modulator of Immunotherapy and Immune Response in Melanoma
Mai-Huong Thi Nguyen, Yueh-Hsia Luo, An-Lun Li, Jen-Chieh Tsai, Kun‐Lin Wu, Pei‐Jung Chung, Nianhan Jia-Lin Ma · 2021 · Biomolecules
Next-generation sequencing: unraveling genetic mechanisms that shape cancer immunotherapy efficacy
Ahmed Halima, Winston Vuong, Timothy An-thy Chan · 2022 · Journal of Clinical Investigation
NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective Therapeutic Targets
Alice Indini, Irene Fiorilla, Luca Ponzone, Enzo Calautti, Valentina Audrito · 2022 · International Journal of Molecular Sciences
Current landscape and future directions of biomarkers for predicting responses to immune checkpoint inhibitors
Yingming Zhu, Fen qin Zhao, Zhenxiang Li, Jinming Yu · 2018 · Cancer Management and Research
Strategies for Predicting Response to Checkpoint Inhibitors
Roberta Zappasodi, Jedd D. Wolchok, Taha Merghoub · 2018 · Current Hematologic Malignancy Reports
HDACi delivery reprograms tumor-infiltrating myeloid cells to eliminate antigen-loss variants
Nguyen, Andrew, Ho, Louisa, Workenhe, Samuel T., Chen, Lan, Samson, Jonathan, Walsh, Scott R., Pol, Jonathan, Bramson, Jonathan L., Wan, Yonghong · 2018 · Cell Reports
Construction of a Promising Tumor-Infiltrating CD8+ T Cells Gene Signature to Improve Prediction of the Prognosis and Immune Response of Uveal Melanoma
Yifang Sun, Jian Wu, Yonggang Yuan, Yumin Lu, Ming Luo, Ling Lin, Shengsheng Ma · 2021 · Frontiers in Cell and Developmental Biology
Role of Hypoxia in the Interferon Response
Esther Arnaiz, Adrian Llewellyn Harris · 2022 · Frontiers in Immunology
PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer
Lestat R. Ali, Patrick J. Lenehan, Victoire Cardot‐Ruffino, Andressa Dias Costa, Matthew H. G. Katz, Todd W. Bauer, Jonathan Andrew Nowak, Brian Matthew Wolpin, Thomas Adam Abrams, Anuj Kishor Patel et al. · 2023 · Clinical Cancer Research
Further knowledge and developments in resistance mechanisms to immune checkpoint inhibitors
Léa Berland, Zeina Gabr, Michelle Chang, Marius Ilié, Véronique Hofman, Guylène Rignol, François Ghiringhelli, Baharia Mograbi, Mohamad Rashidian, Paul M Hofman · 2024 · Frontiers in Immunology
Metabolic reprograming mediated by tumor cell-intrinsic type I IFN signaling is required for CD47-SIRPα blockade efficacy
Hang Zhou, Wenjun Wang, Hairong Xu, Yong Liang, Jiyu Ding, Mengjie Lv, Boyang Ren, Hua Peng, Yang‐Xin Fu, Mingzhao Zhu · 2024 · Nature Communications
Oncogenic KRAS drives immunosuppression of colorectal cancer by impairing DDX60-mediated dsRNA accumulation and viral mimicry
Yi Zhou, Yaxin Zhang, Mingzhou Li, Tian Ming, Chao Zhang, Chengmei Huang, Jiexi Li, Fengtian Li, H.‐B. Li, Enen Zhao et al. · 2024 · Science Immunology
OMIC signatures to understand cancer immunosurveillance and immunoediting: Melanoma and immune cells interplay in immunotherapy
Ricardo A. Léon-Letelier, Laura C. Bonifaz, Ezequiel M. Fuentes‐Pananá · 2019 · Journal of Leukocyte Biology
Evolution of the nonsense-mediated decay pathway is associated with decreased cytolytic immune infiltration
Boyang Zhao, Justin R. Pritchard · 2019 · PLoS Computational Biology
Translational Biomarkers and Rationale Strategies to Overcome Resistance to Immune Checkpoint Inhibitors in Solid Tumors
Justin A. Chen, Weijie Ma, Jianda D. Yuan, Tianhong Li · 2020 · Cancer treatment and research
Th1-Dominant CD4+ T Cells Orchestrate Endogenous Systematic Antitumor Immune Memory After Cryo-Thermal Therapy
Peng Peng, Yue Lou, Junjun Wang, Shicheng Wang, Ping Liu, Lisa Xuemin Xu · 2022 · Frontiers in Immunology
Selective suppression of melanoma lacking IFN-γ pathway by JAK inhibition depends on T cells and host TNF signaling
Hongxing Shen, Fengyuan Huang, Xiangmin Zhang, Oluwagbemiga A. Ojo, Yuebin Li, Hoa Quang Trummell, Joshua Charles Anderson, John B. Fiveash, Markus Bredel, Eddy Shih-Hsin Yang et al. · 2022 · Nature Communications
IFNγ is a central node of cancer immune equilibrium
Michael J. Walsh, Courtney T. Stump, Rakeeb Kureshi, Patrick J. Lenehan, Lestat R. Ali, Michael Lawrence Dougan, David M. Knipe, Stephanie K. Dougan · 2023 · Cell Reports
Immunosuppressive Tumor Microenvironment Status and Histological Grading of Endometrial Carcinoma
Julie Antomarchi, Damien Ambrosetti, Charlotte Cohen, J. Delotte, Anne Chevallier, B Karimdjee-Soilihi, Mélanie Ngo‐Mai, Annie Schmid‐Alliana, Heidy Schmid‐Antomarchi · 2019 · Cancer Microenvironment
TGFβ Antagonizes IFNγ-Mediated Adaptive Immune Evasion via Activation of the AKT–Smad3–SHP1 Axis in Lung Adenocarcinoma
Fan Ye, Zihao Cai, Boyu Wang, Chenxi Zeng, Yu Xi, Shaojie Hu, Rirong Qu, Zhiwei Yuan, Jiaqi Yue, Yitao Tian et al. · 2023 · Cancer Research
Chronic Heat Stress Induces Oxidative Stress and Induces Inflammatory Injury in Broiler Spleen via TLRs/MyD88/NF-κB Signaling Pathway in Broilers
Haoxiang Chen, Feiyao Wang, Xingyue Wu, Songchen Yuan, Huili Dong, Chenyang Zhou, Siliang Feng, Zhanqin Zhao, Lifang Si · 2024 · Veterinary Sciences
IFNγ enhances cytotoxic efficiency of the cytotoxic T lymphocytes against human glioma cells
Shengwen Shao, Eric Risch, Danielle Burner, Lingeng Lu, Boris Minev, Wenxue Ma · 2017 · International Immunopharmacology
Overcoming Oncogenic Mediated Tumor Immunity in Prostate Cancer
Geoffrey Bryant, Lin Wang, David J. Mulholland · 2017 · International Journal of Molecular Sciences
Molecular Biomarkers of Primary and Acquired Resistance to T-Cell-Mediated Immunotherapy in Cancer: Landscape, Clinical Implications, and Future Directions
Young Kwang Chae, Michael S. Oh, Francis Joseph Giles · 2017 · The Oncologist
Interferon signaling during Hepatitis B Virus (HBV) infection and HBV-associated hepatocellular carcinoma
Saravana Kumar Kailasam Mani, OURANIA M. ANDRISANI · 2018 · Cytokine
USP22 deficiency in melanoma mediates resistance to T cells through IFNγ-JAK1-STAT1 signal axis
Min Li, Yanqin Xu, Jie Liang, Hao Ran Lin, Xinyue Qi, Fanlin Li, Ping Han, Yanfeng Gao, Xuanming Yang · 2021 · Molecular Therapy
Checkpoint blockade toxicities: Insights into autoimmunity and treatment
Michael J. Walsh, Michael Lawrence Dougan · 2021 · Seminars in Immunology
PKCλ/ι inhibition activates an ULK2-mediated interferon response to repress tumorigenesis
Juan F. Linares, Xiao Zhang, Anxo Martínez-Ordóñez, Ángeles Durán, Hiroto Kinoshita, Hiroaki Kasashima, Naoko Nakanishi, Yuki Nakanishi, Ryan Carelli, Luca Vincenzo Cappelli et al. · 2021 · Molecular Cell
Interferon-γ increases sensitivity to chemotherapy and provides immunotherapy targets in models of metastatic castration-resistant prostate cancer
Dimitrios K. Korentzelos, Alan H. Wells, Amanda M. Clark · 2022 · Scientific Reports
PRC2-Mediated Epigenetic Suppression of Type I IFN-STAT2 Signaling Impairs Antitumor Immunity in Luminal Breast Cancer
Juyeong Hong, Ji Hoon Lee, Zhao Zhang, Yanming Wu, Mei Yang, Yiji Liao, Richard de la Rosa, Jessica L. Scheirer, Douglas Pechacek, Nu Zhang et al. · 2022 · Cancer Research
Genetic dysregulation of immunologic and oncogenic signaling pathways associated with tumor-intrinsic immune resistance: a molecular basis for combination targeted therapy-immunotherapy for cancer
Kristian Michael Hargadon · 2023 · Cellular and Molecular Life Sciences
The Role of Immune Checkpoint Inhibition in the Treatment of Brain Tumors
Andrew S. Luksik, Russell Maxwell, Tomás Garzón-Muvdi, Michael K. Lim · 2017 · Neurotherapeutics
Human preprocalcitonin self-antigen generates TAP-dependent and -independent epitopes triggering optimised T-cell responses toward immune-escaped tumours
Aurélie Durgeau, Yasemin Virk, Gwendoline Gros, Elodie Voilin, Stéphanie Corgnac, Fayçal Djenidi, Jérôme Salmon, Julien Adam, Vincent de Montpréville, Pierre Validire et al. · 2018 · Nature Communications
Soluble NKG2D ligands limit the efficacy of immune checkpoint blockade
Alejandro López‐Soto, Segundo R. Gonzalez, Lorenzo Galluzzi · 2017 · OncoImmunology
Current Technologies and Future Perspectives in Immunotherapy towards a Clinical Oncology Approach
Subhamay Adhikary, Surajit Pathak, Vignesh Palani, Ahmet Acar, Antara Banerjee, Nader Izz Eddin Al-Dewik, Musthafa Mohamed Essa, Sawsan G. A. A. Mohammed, M. Walid Qoronfleh · 2024 · Biomedicines
Targeted therapy, immunotherapy, and small molecules and peptidomimetics as emerging immunoregulatory agents for melanoma
Jingwen Zhang, Anthony Michael Joshua, Yue Li, Connor H. O’Meara, Margaret J. Morris, Levon Michael Khachigian · 2024 · Cancer Letters
Hypoxia-Induced Long Noncoding RNA HIF1A- AS2 Regulates Stability of MHC Class I Protein in Head and Neck Cancer
Tsai‐Tsen Liao, Yu-Hsien Chen, Zih-Yu Li, An-Ching Hsiao, Ya-Li Huang, Ruo-Xin Hao, Shyh‐Kuan Tai, Pen‐Yuan Chu, Jing-Wen Shih, Hsing‐Jien Kung et al. · 2024 · Cancer Immunology Research
Syndecan-1 inhibition promotes antitumor immune response and facilitates the efficacy of anti-PD1 checkpoint immunotherapy
Yun Liu, Chen Xu, Li Zhang, Guiqin Xu, Zhaojuan Yang, Lvzhu Xiang, Kun Jiao, Zehong Chen, Xiaoren Zhang, Yongzhong Liu · 2024 · Science Advances
An update on the clinical trial research of immunotherapy for glioblastoma
Yichen Zhou, Fanxing Shi, Junyu Zhu, Yi Yuan · 2025 · Frontiers in Immunology
Aberrant modulation of ribosomal protein S6 phosphorylation confers acquired resistance to MAPK pathway inhibitors in BRAF-mutant melanoma
Mingzhao Gao, Hongbin Wang, Xiangling Chen, Wen-ting Cao, Fu Li, Yun Li, Haitian Quan, Chengying Xie, Liguang Lou · 2018 · Acta Pharmacologica Sinica
Cytosolic Processing Governs TAP-Independent Presentation of a Critical Melanoma Antigen
Nathalie Vigneron, Violette Ferrari, Benoit J. Van den Eynde, Peter Cresswell, Ralf M. Leonhardt · 2018 · The Journal of Immunology
Melanoma Metabolism: Cell Survival and Resistance to Therapy
Rafael Luís, Cheila Brito, Marta Pojo · 2020 · Advances in experimental medicine and biology
Perdurable PD-1 blockage awakes anti-tumor immunity suppressed by precise chemotherapy
Mengshi Jiang, Wei Li, Chunqi Zhu, Xiang Li, Junlei Zhang, Zhenyu Luo, Bing Qin, Yongzhong Du, Lihua Luo, Jian You · 2020 · Journal of Controlled Release
Neoangiogenesis in Melanoma: An Issue in Biology and Systemic Treatment
Davide Quaresmini, Michele Guida · 2020 · Frontiers in Immunology
Addressing Resistance to Immune Checkpoint Inhibitor Therapy: An Urgent Unmet Need
Siwen Hu‐Lieskovan, Gabriel G. Malouf, Ira Allen Jacobs, Jeffrey Chou, Li Liu, Melissa Lynne Johnson · 2021 · Future Oncology
Understanding the Immune-Stroma Microenvironment in B Cell Malignancies for Effective Immunotherapy
Benedetta Apollonio, Nikolaos Ioannou, Despoina Papazoglou, Alan G. Ramsay · 2021 · Frontiers in Oncology
Greek Fire, Poison Arrows, and Scorpion Bombs: How Tumor Cells Defend Against the Siege Weapons of Cytotoxic T Lymphocytes
Brienne McKenzie, Roxana Khazen, Salvatore Valitutti · 2022 · Frontiers in Immunology
Immune surveillance of brain metastatic cancer cells is mediated by IFITM1
Xiaofei She, Shijun Shen, Guang Chen, Yaqun Gao, Junxian Ma, Yaohui Gao, Yingdi Liu, Guoli Gao, Yan Fang Zhao, Chunyan Wang et al. · 2023 · The EMBO Journal
Opposing tumor-cell-intrinsic and -extrinsic roles of the IRF1 transcription factor in antitumor immunity
Prabhat Kumar Purbey, Joowon Seo, Manash Kumar Paul, Keisuke S. Iwamoto, Allison E. Daly, An‐Chieh Feng, Ameya S. Champhekar, Justin Langerman, Katie Marie Campbell, Dörthe Schaue et al. · 2024 · Cell Reports
Chitosan/γ-PGA nanoparticles and IFN-γ immunotherapy: A dual approach for triple-negative breast cancer treatment
Flávia Castro, Marta L. Pinto, Catarina Leite Pereira, Karine Serre, Ângela M. Costa, Bruno Cavadas, Mário Adolfo Barbosa, Karim Y. Vermaelen, Sergio León, Diego Serrano et al. · 2025 · Journal of Controlled Release
TET2-mutant clonal hematopoiesis enhances macrophage antigen presentation and improves immune checkpoint therapy in solid tumors
Shelley M. Herbrich, Mehdi Chaib, Swetha Anandhan, Samuel W. Andrewes, Ashwat Nagarajan, Baoxiang Guan, Nishant S. Gandhi, Jared C. Gilliam, Milan Radovich, Padmanee Sharma et al. · 2025 · Cancer Cell
Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8+ T Cell–Effector Responses
Eleanor Clancy‐Thompson, Christine A. Devlin, Paul M. Tyler, Mariah M. Servos, Lestat R. Ali, Katherine S. Ventre, M. Aladdin Bhuiyan, Patrick T. Bruck, Michael E. Birnbaum, Stephanie K. Dougan · 2018 · Cancer Immunology Research
Review of biomarkers for response to immunotherapy in HNSCC microenvironment
Shaoshi Chen, Yifan Yang, Shizhi He, Meng Lian, Ru Wang, Jugao Fang · 2023 · Frontiers in Oncology
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma
Giulia Francesca Manfredi, Ciro Celsa, Chloe John, Charlotte Jones, Nicole Acuti, Bernhard Scheiner, Claudia Angela Maria Fulgenzi, James Korolewicz, Matthias Pinter, Alessandra Gennari et al. · 2023 · Journal of Hepatocellular Carcinoma
Regression and Eradication of Triple-Negative Breast Carcinoma in 4T1 Mouse Model by Combination Immunotherapies
Saifun Nahar, Yue Huang, Bethany A. Nagy, John A. Zebala, Dean Y. Maeda, Udo Rudloff, Joost J. Oppenheim, De Yang · 2023 · Cancers
Understanding immune checkpoints and PD-1/PD-L1-mediated immune resistance towards tumour immunotherapy
S. D. Singh, Navneet Singh, Manoj Baranwal, Siddharth Sharma, Shilpa Devi, Sandeep Kumar · 2023 · 3 Biotech
Understanding and overcoming resistance to immunotherapy in genitourinary cancers
Sean T Evans, Yash C. Jani, Caroline Stewart Jansen, Ahmet Yıldırım, Ecem Kalemoglu, Mehmet Asım Bilen · 2024 · Cancer Biology & Therapy
INHBA promotes tumor growth and induces resistance to PD-L1 blockade by suppressing IFN-γ signaling
Fanglin Li, Longhua Gu, Yong-liang Tong, Run-qiu Chen, Shiyi Chen, Xiaolu Yu, Nan Liu, Jiang-ling Lu, Yuan Si, Jianhua Sun et al. · 2024 · Acta Pharmacologica Sinica
Oncolytic virus OH2 extends survival in patients with PD-1 pretreated melanoma: phase Ia/Ib trial results and biomarker insights
Xuan Wang, Hui Tian, Zhihong Chi, Lu Si, Xinan Sheng, Han Hu, Xiangyong Gu, Siming Li, Caili Li, Bin Lian et al. · 2025 · Journal for ImmunoTherapy of Cancer
Tumor Membrane Vesicle Vaccine Augments the Efficacy of Anti-PD1 Antibody in Immune Checkpoint Inhibitor-Resistant Squamous Cell Carcinoma Models of Head and Neck Cancer
Ramireddy Bommireddy, Luis E. Muñoz, Anita Kumari, Lei Huang, Yijian Fan, Lenore Monterroza, Christopher D. Pack, Sampath Ramachandiran, Shaker J. C. Reddy, Janet Kim et al. · 2020 · Vaccines
Understanding and Overcoming the Inflammatory Toxicities of Immunotherapy
Michael Lawrence Dougan · 2020 · Cancer Immunology Research
Integrative transcriptome analysis of malignant pleural mesothelioma reveals a clinically relevant immune-based classification
Ania Alay, David Cordero, Sara Hijazo‐Pechero, Elisabet Aliagas, Adriana López‐Doriga, Raúl Marín, Ramón Palmero, Roger Llatjós, Ignacio Escobar, Ricard Ramos et al. · 2021 · Journal for ImmunoTherapy of Cancer
Resistance mechanisms to checkpoint inhibitors
Sarah Ann Weiss, Mario Sznol · 2021 · Current Opinion in Immunology
Durable responses in patients with genitourinary cancers following immune checkpoint therapy rechallenge after moderate-to-severe immune-related adverse events
Bilal Ahmed Siddiqui, Jinesh Gheeya, Rohit Vivek Goswamy, Tharakeswara Kumar Bathala, Devaki Shilpa Surasi, Jianjun Gao, Amishi Yogesh Shah, Matthew T. Campbell, Pavlos Msaouel, Sangeeta Goswami et al. · 2021 · Journal for ImmunoTherapy of Cancer
Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer Immunotherapy
Xue‐Bin Ran, Ling‐Wen Ding, Qiao-Yang Sun, Henry He Yang, Jonathan W. Said, Zhentang Lao, Vikas Madan, Pushkar Dakle, Jin-Fen Xiao, Xin-Yi Loh et al. · 2023 · Cancer Research
Deciphering the tumor-suppressive role of PSMB9 in melanoma through multi-omics and single-cell transcriptome analyses
Xing Hu, Zhengang Hu, Hao Zhang, Nan Zhang, Hao Feng, Xiaomin Jia, Chi Zhang, Quan Cheng · 2023 · Cancer Letters
T cells specific for a TAP-independent self-peptide remain naïve in tumor-bearing mice and are fully exploitable for therapy
Elien M. Doorduijn, Marjolein Sluijter, Koen A. Marijt, Bianca J. Querido, Sjoerd H. van der Burg, Thorbald van Hall · 2017 · OncoImmunology
A mathematical model of tumor-immune interactions with an immune checkpoint inhibitor
Jui‐Ling Yu, Sophia R.‐J. Jang · 2019 · Applied Mathematics and Computation
The pioneers behind immune checkpoint blockers awarded the Nobel Prize in physiology or medicine 2018
Olav Dahl, Marianne Brydøy · 2019 · Acta Oncologica
Could the menagerie of the gut microbiome really cure cancer? Hope or hype
Muhammad Bilal Abid · 2019 · Journal for ImmunoTherapy of Cancer
Resistance mechanisms in melanoma to immuneoncologic therapy with checkpoint inhibitors
Sarah Elizabeth Fenton, Jeffrey Alan Sosman, Sunandana Chandra · 2019 · Cancer Drug Resistance
ERK mediates interferon gamma-induced melanoma cell death
Ameya S. Champhekar, Rachel Heymans, Justin D. Saco, Guillem Turon Font, Cynthia R. Gonzalez, Anne Gao, John D. Pham, June Lee, Ryan Maryoung, Egmidio Medina et al. · 2023 · Molecular Cancer
Rising Star in Immunotherapy: Development and Therapeutic Potential of Small-Molecule Inhibitors Targeting Casitas B Cell Lymphoma-b (Cbl-b)
Lixin Zhou, Jiamei Yang, Kuojun Zhang, Tianyu Wang, Sheng Jiang, Xiangyu Zhang · 2024 · Journal of Medicinal Chemistry
Deletion of the mRNA endonuclease Regnase-1 promotes NK cell anti-tumor activity via OCT2-dependent transcription of Ifng
Xin Sun, Yasuharu Nagahama, Shailendra Kumar Singh, Yuuki Kozakai, Hiroshi Nabeshima, Kiyoharu Fukushima, Hiroki Tanaka, Daisuke Motooka, Eriko Fukui, Éric Vivier et al. · 2024 · Immunity
Combining ERBB family and MET inhibitors is an effective therapeutic strategy in cutaneous malignant melanoma independent of BRAF/NRAS mutation status
I. Das, M. Wilhelm, V. Höiom, Rodolfo Franco Marquez, F. Costa Svedman, J. Hansson, Rainer Tuominen, Suzanne Egyházi Brage · 2019 · Cell Death and Disease
p110δ PI3K as a therapeutic target of solid tumours
Lydia Xenou, Evangelia A. Papakonstanti · 2020 · Clinical Science
Informatics for cancer immunotherapy
Jeff Hammerbacher, Alexandra Snyder · 2017 · Annals of Oncology
DOCK8 Drives Src-Dependent NK Cell Effector Function
Kearney, Conor J, Vervoort, Stephin J, Ramsbottom, Kelly M, Freeman, Andrew J, Michie, Jessica, Peake, Jane, Casanova, Jean-Laurent, Picard, Capucine, Tangye, Stuart G, Ma, Cindy S et al. · 2017 · The Journal of Immunology
Inhibition of urothelial carcinoma through targeted type I interferon-mediated immune activation
Devin Plote, Woonyoung Choi, Sharada Mokkapati, Debasish Sundi, James E. Ferguson, Jonathan J. Duplisea, Nigel R. Parker, Seppo Ylä‐Herttuala, SUO CTC Bladder Committee, David James McConkey et al. · 2019 · OncoImmunology
Combinations of immuno-checkpoint inhibitors predictive biomarkers only marginally improve their individual accuracy
Matteo Pallocca, D. Angeli, F. Palombo, F. Sperati, M. Milella, F. Goeman, F. de Nicola, M. Fanciulli, P. Nisticò, C. Quintarelli et al. · 2019 · Journal of Translational Medicine
Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma
Tao T. Fan, Shize Pan, Shuo Yang, Bo Hao, Lin Zhang, Donghang Li, Qing Geng · 2021 · Frontiers in Immunology
An immunotherapy response prediction model derived from proliferative CD4+ T cells and antigen-presenting monocytes in ccRCC
Kun Chan Zheng, Lianchong Gao, Jie Hao, Xin Zou, Xiaoyong Hu · 2022 · Frontiers in Immunology
Inhibitor of Apoptosis Proteins Antagonist Induces T-cell Proliferation after Cross-Presentation by Dendritic Cells
Esmée P. Hoefsmit, Paula T. van Royen, Disha Rao, Johanna A. Stunnenberg, Petros Dimitriadis, Cor Lieftink, Ben Morris, Elisa A. Rozeman, Irene L. M. Reijers, Ruben Lacroix et al. · 2023 · Cancer Immunology Research
Mapping the functional interactions at the tumor-immune checkpoint interface
Behnaz Bozorgui, Elisabeth Kong, Augustin Luna, Anil Korkut · 2023 · Communications Biology
Genome-wide CRISPR screens define determinants of epithelial-mesenchymal transition mediated immune evasion by pancreatic cancer cells
Yuanzhuo Gu, Zhengkui Zhang, Marcel G M Camps, FERRY A. OSSENDORP, Ruud H. M. Wijdeven, Peter ten Dijke · 2023 · Science Advances
Biomarkers for Immune Checkpoint Inhibitors in Renal Cell Carcinoma
Spencer D. Martin, Ishmam Bhuiyan, Maryam Soleimani, Gang Wang · 2023 · Journal of Clinical Medicine
Unraveling the Intricacies of CD73/Adenosine Signaling: The Pulmonary Immune and Stromal Microenvironment in Lung Cancer
Maria Saigí, Oscar Mesía-Carbonell, David Allen Barbie, Raquel Guillamat‐Prats · 2023 · Cancers